UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
September 15, 2017
Date of Report (Date of earliest event reported)
Canbiola, Inc.
(Exact name of registrant as specified in its charter)
Florida |
| ____333-208293_______ |
| 20-3624118 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No. |
445 NE 12th Ave. Fort Lauderdale, Florida |
| 33301 |
(Address of principal executive offices) |
| (Zip Code) |
Registrants telephone number, including area code 516-205-4751
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
1
Item 1.01. Entry into a Material Definitive Agreement.
On September 15, 2017, Canbiola, Inc. (the “Company”) and Fratellone Associates LLP (Fratellone) entered into a Consulting Agreement (the Agreement). Pursuant to the Agreement, Fratellone will provide strategic planning and marketing services, from a medical standpoint, to the Company. The term of the Agreement began on September 15, 2017 and will end on September 20, 2018, unless earlier terminated pursuant to Section 7 of the Agreement. As compensation for its services, Fratellone shall receive 1,000,000 restricted shares of common stock, of which (i) 250,000 vested on September 20, 2017, (ii) 250,000 shall vest on December 20, 2017, (iii) 250,000 shall vest on March 20, 2018, and (iv) 250,000 shall vest on April 20, 2018.
Item 3.02. Unregistered Sales of Equity Securities.
See disclosure in item 1.01, incorporated herein by reference, with regards to the issuance of shares to Fratellone.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Canbiola, Inc. |
| ||
|
|
|
| |
Date: September 20, 2017 | By: | ___/s/ Marco Alfonsi________ Marco Alfonsi, CEO |
| |
|
|
|
3